SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-064663
Filing Date
2023-05-25
Accepted
2023-05-25 16:32:43
Documents
13
Period of Report
2023-05-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2316983d1_8k.htm   iXBRL 8-K 28582
2 EXHIBIT 10.1 tm2316983d1_ex10-1.htm EX-10.1 27823
  Complete submission text file 0001104659-23-064663.txt   236793

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bpmc-20230522.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bpmc-20230522_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bpmc-20230522_pre.xml EX-101.PRE 22615
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2316983d1_8k_htm.xml XML 3495
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 23961281
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences